Fenwick has been named a Law360 Capital Markets Group of the Year on the publication’s annual list that recognizes leadership in landmark matters and general excellence.
In 2019, Fenwick’s capital markets lawyers handled significant initial public offerings and other capital markets transactions for leading technology companies, including guiding one of the year’s largest tech IPOs—Peloton’s $1.2 billion IPO. The firm also handled Bill.com’s IPO and represented the underwriters in Cloudflare’s $525 million IPO.
Fenwick also helped take multiple life sciences innovators public. Notably, in the span of just one month during summer 2019, the firm helped steer three major IPOs: Morphic’s $103.5 million IPO, Stoke Therapeutics’ $163 million IPO and Adaptive Biotechnologies’ $345 million IPO (underwriter representation).
Chaired by partners James Evans and Robert Freedman, Fenwick’s capital markets & public companies group has deep experience in public offerings, corporate governance and other securities matters. The firm is one the nation’s most active in representing technology and life sciences companies in their IPOs and other equity and debt offerings.
Fenwick regularly receives recognition for its capital markets work. The firm was recently ranked among the top two in the United States and in the top three worldwide in gross proceeds for technology IPOs over $150 million, according to Dealpoint. The Legal 500 also honored Fenwick among the nation’s leading capital markets practices in 2019.
To learn more about the Law360 Capital Markets of Group of the Year list, visit the Law360 website.